Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10838296 | Pharmacology Biochemistry and Behavior | 2011 | 9 Pages |
Abstract
⺠DOV 216,303 increased monoamine release in PFC and DH even five weeks after OBX. ⺠Extracellular DA levels in PFC lower in OBX than shams after acute DOV 216,303. ⺠DOV 216,303-challenge leads to blunted DA response in chronic DOV-treated shams. ⺠Brain and plasma levels of DOV lower after chronic compared to acute treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
J. Prins, K.G.C. Westphal, G.A.H. Korte-Bouws, M.S. Quinton, R. Schreiber, B. Olivier, S.M. Korte,